Leading scientists continue to remove roadblocks by developing methods for synthesizing psychedelic compounds for further research.
The Mental Organs Hypothesis reconsiders the relationship between 5-HT2 receptors and the qualitative effects of psychedelics.
Identification of psychoplastogenic isoDMT analogs is a concrete step forward in using psychedelics for treating patients who suffer from depression.
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.
Novel chemical variants of ibogaine may offer therapeutic benefits without severe side effects.
“I believe one person can produce enough 5-MeO-DMT to supply everyone that would ever want it.”
Researchers at the forefront of psychedelic science put forth their arguments in this important debate.
This study provides meaningful access to some lesser-known magic mushroom compounds and conducts biological testing on them for the first time.
The characterization of methoxetamine, a ketamine analog, and how its action on the serotonin system sets it apart.
Brain imaging research reveals where psychedelic compounds such as psilocybin and LSD manifest their effects.